Pneumococcal sepsis in patients with systemic lupus erythematosus

Lupus

Volumn 14, Issue 11, 2005, Pages 903-906

  Naveau, C ^a   Houssiau, Frédéric A ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Immunization; Pneumococcal septicaemia; SLE; Streptococcus pneumoniae

Indexed keywords

POLYSACCHARIDE VACCINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; CHILD; ENCEPHALITIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; SEPSIS; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE;

EID: 28444458477     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2242xx     Document Type: Article

References (24)

1. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1999; 78: 167-175.
2. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore) 2003; 82: 299-308.
3. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003; 15: 528-534.
4. Gladman DD, Hussain F, Ibanez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus 2002; 11: 234-239.
5. Dillon AM, Stein HB, Kassen BO, Ibbott JW. Hyposplenia in a patient with systemic lupus erythematosus. J Rheumatol 1980; 7: 196-198.
6. Garred P, Madsen HO, Halberg P et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2145-2152.
7. Lauwerys BR, Garot N, Renauld JC, Houssiau FA. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheum 2000; 43: 1976-1981.
8. Van Der Straeten C, Wei N, Rothschild J, Goozh JL, Klippel JH. Rapidly fatal pneumococcal septicemia in systemic lupus erythematosus. J Rheumatol 1987; 14: 1177-1180.
9. Petros D, West S. Overwhelming pneumococcal bacteraemia in systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 333-335.
10. Hill MD, Karsh J. Invasive soft tissue infections with streptococcus pneumoniae in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1716-1719.
11. Mackenzie AR, Laing RBS, MacDonald AG, Smith CC. Pneumococcal septicaemia in a patient with systemic lupus erythematosus. Ann Rheum Dis 1997; 56: 403-404.
12. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 37-44.
13. Austrian R, Douglas RM, Schiffman G et al. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 1976; 89: 184-194.
14. Shapiro ED, Berg AT, Austrian R et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453-1460.
15. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993; 270: 1826-1831.
16. Jackson LA, Neuzil KM, Yu O et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348: 1747-1755.
17. Dear K, Holden J, Andrews R, Tatham D. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2003; 4: CD000422.
18. Klippel JH, Karsh J, Stahl NI, Decker JL, Steinberg AD, Schiffman G. A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 1321-1325.
19. Jarrett MP, Schiffman G, Barland P, Grayzel AI. Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum 1980; 23: 1287-1293.
20. Lipnick RN, Karsh J, Stahl NI, Blackwelder WC, Schiffman G, Klippel JH. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol 1985; 12: 1118-1121.
21. Tarjan P, Sipka S, Marodi L et al. No short-term immunological effects of Pneumococcus vaccination in patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 211-215.
22. Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-1746.
23. Reinert RR, Reinert S, van der Linden M, Cil MY, Al-Lahham A, Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005; 49: 2903-2913.
24. Vanhoof R, Carpentier M, Cartuyvels R et al. Surveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001. Acta Clin Belg 2003; 58: 111-119.